Register      Login
Microbiology Australia Microbiology Australia Society
Microbiology Australia, bringing Microbiologists together
RESEARCH ARTICLE

HIV, hepatitis viruses and viral STIs: intertwined fates?

Tony Cunningham
+ Author Affiliations
- Author Affiliations

Westmead Millennium Institute for Medical Research
Darcy Road
PO Box 412
Westmead, NSW 2145, Australia
Tel: +61 2 9845 9001
Fax: +61 2 9845 9100
Email: tony.cunningham@sydney.edu.au

Microbiology Australia 35(2) 83-87 https://doi.org/10.1071/MA14025
Published: 5 May 2014

Abstract

Although the major target cell for HIV in the body is the CD4 lymphocyte, uptake by and infection of other target cells such macrophages and dendritic cells also play a major role in pathogenesis. Macrophages are a major reservoir for HIV in most lymphoid tissue in the untreated patient and remain the major target cell in brain whether the subject is treated or not. Dendritic cells play a major role in transferring HIV efficiently to T cells particularly after viral entry through sexual transmission. Our work has focused on understanding how HIV binds to and enters these cells, trafficks through them and, during that time, alters their function to facilitate viral survival, replication and spread. Understanding of these processes is the foundation for a rational approach to the development of therapeutics (including microbicides) and vaccines.


References

[1]  Cunningham, A.L. et al. (1985) Evolution of recurrent herpes simplex lesions. An immunohistologic study. J. Clin. Invest. 75, 226–233.
Evolution of recurrent herpes simplex lesions. An immunohistologic study.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL2M%2FotVGrsg%3D%3D&md5=a08df63b75b7def96e2ebf7333c57504CAS | 3880773PubMed |

[2]  Cunningham, A.L. et al. (2013) Initial HIV mucosal infection and dendritic cells. EMBO Mol. Med. 5, 658–660.
Initial HIV mucosal infection and dendritic cells.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXntV2hs7c%3D&md5=7cd77757d0b5ca6b7ce1b627be640535CAS | 23653303PubMed |

[3]  Cunningham, A.L. et al. (2008) Langerhans cells and viral immunity. Eur. J. Immunol. 38, 2377–2385.
Langerhans cells and viral immunity.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXht1SnsbfP&md5=b4f64991634dee3cc0b4b054ab838093CAS | 18792031PubMed |

[4]  Cunningham, A.L. et al. (2010) Manipulation of dendritic cell function by viruses. Curr. Opin. Microbiol. 13, 524–529.
Manipulation of dendritic cell function by viruses.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXpvVaqtbo%3D&md5=2a809e72e54ada68320953644888f02cCAS | 20598938PubMed |

[5]  Fear, W.R. et al. (1998) Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J. Virol. 72, 1334–1344.
| 1:CAS:528:DyaK1cXlt12gtw%3D%3D&md5=19a95fe42baf75dc207f8458f3d40c24CAS | 9445034PubMed |

[6]  Kesson, A.M. et al. (1993) Human immunodeficiency virus type 1 infection of human placental macrophages in vitro. J. Infect. Dis. 168, 571–579.
Human immunodeficiency virus type 1 infection of human placental macrophages in vitro.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK3szlvFOnsA%3D%3D&md5=bbec9fb1cbb552bb3b30440d3831572bCAS | 7689088PubMed |

[7]  Cunningham, A.L. et al. (1997) HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype. J. Leukoc. Biol. 62, 117–125.
| 1:CAS:528:DyaK2sXksF2rsr8%3D&md5=6be2102e5dd1b2300faad2c5e8d5fc76CAS | 9226002PubMed |

[8]  Kazazi, F. et al. (1989) Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus. J. Gen. Virol. 70, 2661–2672.
Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaL1MXmtlSnt70%3D&md5=2072f5e7f50812b184c8d7befc5ddb36CAS | 2677236PubMed |

[9]  Naif, H.M. et al. (1998) CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J. Virol. 72, 830–836.
| 1:CAS:528:DyaK1cXhvFCltQ%3D%3D&md5=80c1f63a536f020253f343df11810b32CAS | 9420295PubMed |

[10]  Shen, R. et al. (2011) Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages. PLoS Pathog. 7, e1002060.
Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXntVajsrc%3D&md5=8687f067a126a1086ac52890c81ada06CAS | 21637819PubMed |

[11]  Chang, J. et al. (1996) Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro. J. Virol. 70, 7792–7803.
| 1:CAS:528:DyaK28Xmt1Gksb8%3D&md5=41cd9f4c78053dd4feb2df84804962a8CAS | 8892900PubMed |

[12]  Naif, H.M. et al. (1999) Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J. Virol. 73, 4866–4881.
| 1:CAS:528:DyaK1MXjtFertbw%3D&md5=8817bcaa2ba428135bf72dcdac941b8cCAS | 10233948PubMed |

[13]  Li, S. et al. (1999) Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J. Virol. 73, 9741–9755.
| 1:CAS:528:DyaK1MXnsV2msbw%3D&md5=74c615b353f607f0df8919f386ba07f4CAS | 10559284PubMed |

[14]  Sterjovski, J. et al. (2010) An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes. Virology 404, 269–278.
An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXoslaitbs%3D&md5=b1758cf9b938b187d03e79a145165327CAS | 20570309PubMed |

[15]  Naif, H.M. et al. (2002) A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Δ32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4. J. Virol. 76, 3114–3124.
A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Δ32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD38Xit1GqtbY%3D&md5=c1afb9e3a05c1c2781897198ab8f89d0CAS | 11884536PubMed |

[16]  Kedzierska, K. et al. (2003) The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev. Med. Virol. 13, 39–56.
The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXht1eqtrk%3D&md5=c6c559a0f254f04d8e47720d171222cfCAS | 12516061PubMed |

[17]  Kelly, M.D. et al. (1998) Dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J. Immunol. 160, 3091–3095.
| 1:CAS:528:DyaK1cXitFWntbc%3D&md5=959ad9c6b343b0ebe0ec9c84d940c4ffCAS | 9531262PubMed |

[18]  Maddocks, S. et al. (2009) Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis. Tuberculosis (Edinb.) 89, 285–293.
Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXht1ans73F&md5=57c204fbf0839d133b10c3983cdc8d09CAS | 19520608PubMed |

[19]  Stewart, G.J. et al. (1985) Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet 2, 581–585.
Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL2M3psV2ktg%3D%3D&md5=6312282f8980d151dde884cd26dc14ecCAS | 2863597PubMed |

[20]  Deacon, N.J. et al. (1995) Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988–991.
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK2MXptlOlurY%3D&md5=8e17ce1f5fe12326104e5a6a795a07b2CAS | 7481804PubMed |

[21]  Learmont, J. et al. (1992) Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 340, 863–867.
Long-term symptomless HIV-1 infection in recipients of blood products from a single donor.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK3s%2FitlaisA%3D%3D&md5=d12c61e6b4258ab6e43bea69b7158eb7CAS | 1357294PubMed |

[22]  Puttur, F.K. et al. (2010) Herpes simplex virus infects skin γδ T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation. J. Immunol. 185, 477–487.
Herpes simplex virus infects skin γδ T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXns1CqsLY%3D&md5=b1f076939c218fb84a679679deb9fd9fCAS | 20519652PubMed |

[23]  Turville, S.G. et al. (2001) HIV gp120 receptors on human dendritic cells. Blood 98, 2482–2488.
HIV gp120 receptors on human dendritic cells.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3MXnslCqs70%3D&md5=085aca2daf1be0abfa45ca5e63a5f386CAS | 11588046PubMed |

[24]  Turville, S.G. et al. (2002) Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3, 975–983.
Diversity of receptors binding HIV on dendritic cell subsets.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD38XnsVGrsL0%3D&md5=d7763909829829eafb2c87185dd651d8CAS | 12352970PubMed |

[25]  Turville, S.G. et al. (2004) Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103, 2170–2179.
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXitlequ78%3D&md5=eca87c4841486b66e8446a7ba0d96d3dCAS | 14630806PubMed |

[26]  Harman, A.N. et al. (2009) HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood 114, 85–94.
HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXhtVOkurrK&md5=89df01a13634d9ef481e4bbace563f44CAS | 19436054PubMed |

[27]  Harman, A.N. et al. (2006) HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J. Immunol. 177, 7103–7113.
| 1:CAS:528:DC%2BD28XhtFGrtrvE&md5=94b908db44f65a68eff45220e36af989CAS | 17082627PubMed |

[28]  Mercier, S.K. et al. (2013) The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes. PLoS Pathog. 9, e1003700.
The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes.Crossref | GoogleScholarGoogle Scholar | 24204260PubMed |

[29]  Harman, A.N. et al. (2011) HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 118, 298–308.
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXpsVWmt7c%3D&md5=f93fb3b9a09424444d2f3c7baaa248d4CAS | 21411754PubMed |

[30]  Nasr, N. et al. (2012) HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 120, 778–788.
HIV-1 infection of human macrophages directly induces viperin which inhibits viral production.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtFOgurrN&md5=fb565c8f52bc46fff82bb7745ad859d4CAS | 22677126PubMed |